Description
Product Description
CNOGA TensorTip COMBO GLUCOMETER (CoG)
THE CoG STORY
Non-invasive Hybrid Glucometer provides you a better tool to manage your diabetes
Cnoga Medical TensorTip Combo Glucometer (CoG) is a personalized hybrid non-invasive and invasive glucometer that allows you to monitor your glucose levels frequently without constant pricking. Frequent glucose measurement can help you improve your lifestyle management for better glucose level control. Better diabetes management will not only lower your HbA1C but more importantly prevent future disease complications
Hybrid – Two devices in One
- During the initial calibration period, you need to measure your glucose levels invasively and non-invasively simultaneously usually for 3 days
- After the initial calibration, the invasive component is calibrating the non-invasive component in order to adjust to your daily changing glucose patterns and your lifestyle
The CoG provides instant glucose and HbA1C tests as frequently as you want
- HbA1C test reflects your blood sugar control over the past 3 months. Testing your HbA1C level is the common way for you and your doctor to understand how well your blood sugar levels are controlled
- Frequent glucose monitoring improves awareness of your glucose patterns and thus assists you in complying with the diet that is right for you, persist with physical activity, adjusting medicine and more, all to better control your glucose levels
HOW IT WORKS
Four light-emitting diodes (LEDs) within the finger compartment emit a discrete wavelength from ~ 600 ~ 1000 nm through the fingertip. As the light wave passes through the tissue and blood capillaries, the light is partially absorbed and consequently, the light signal is changed. The traversed light is then projected onto a color image sensor (camera). The unique high-resolution camera photographs in real time the light that traverses the fingertip tissue. The color images are stored in a digital memory for analysis by a dedicated algorithm
Reviews
There are no reviews yet.